Page last updated: 2024-08-21
isoxazoles and Lymphoma, Mantle-Cell
isoxazoles has been researched along with Lymphoma, Mantle-Cell in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bararia, D; Bird, L; Christie, AL; Christodoulou, A; Haebe, S; Jacobson, C; Kopp, N; Layer, JV; Redd, RA; Rodig, SJ; Saur, A; Tivey, T; Tschuri, S; van Bodegom, D; Weigert, O; Weinstock, DM; Zapf, S; Zimber-Strobl, U | 1 |
Other Studies
1 other study(ies) available for isoxazoles and Lymphoma, Mantle-Cell
| Article | Year |
|---|---|
HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Amino Acid Substitution; Animals; Cell Line, Tumor; Drug Resistance, Neoplasm; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Lymphoma, Mantle-Cell; Mice; Mutation, Missense; Piperidines; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Resorcinols; Xenograft Model Antitumor Assays | 2016 |